药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levorphanol
Entinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Entinostat.
Levorphanol
Mocetinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mocetinostat.
Levorphanol
Amifampridine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Amifampridine.
Levorphanol
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Dexchlorpheniramine maleate.
Levorphanol
Benidipine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Benidipine.
Levorphanol
Melperone
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Melperone.
Levorphanol
Butriptyline
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Butriptyline.
Levorphanol
Eperisone
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Eperisone.
Levorphanol
Fendiline
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Fendiline.
Levorphanol
Indenolol
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Indenolol.
Levorphanol
Bedaquiline
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bedaquiline.
Levorphanol
Antazoline
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Antazoline.
Levorphanol
Nemonoxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Nemonoxacin.
Levorphanol
Telavancin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Telavancin.
Levorphanol
Tucidinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tucidinostat.
Levorphanol
Tedisamil
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tedisamil.
Levorphanol
Garenoxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Garenoxacin.
Levorphanol
Technetium Tc-99m ciprofloxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Technetium Tc-99m ciprofloxacin.
Levorphanol
Pracinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pracinostat.
Levorphanol
Azimilide
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Azimilide.